Home Biocodex USA Acquires Totect, Antidote For Unintended Tissue Damage From Chemotherapy
 

Keywords :   


Biocodex USA Acquires Totect, Antidote For Unintended Tissue Damage From Chemotherapy

2013-04-02 09:00:00| drugdiscoveryonline News Articles

Biocodex USA announced recently its acquisition of the oncology supportive care product, Totect from Apricus Biosciences

Tags: usa damage tissue chemotherapy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
More »